Karyopharm Therapeutics Secures $30M Private Placement with RA Capital Management

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it has entered into... Read More
The post Karyopharm Therapeutics Secures $30M Private Placement with RA Capital Management appeared first on citybiz.
